---
schema_version: "secwatch.filing_event.v1"
accession: "0001714899-24-000125"
form_type: "8-K"
ticker: "DNLI"
cik: "0001714899"
company_name: "Denali Therapeutics Inc."
filed_at: "2024-05-31T23:59:59+00:00"
generated_at: "2026-06-01T07:12:02.927658+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Denali shareholders elect directors, ratify auditor, approve executive compensation

## Summary
- Three Class I directors elected: Jay Flatley (108.1M for), Mac Tessier-Lavigne (82.2M for), Nancy Thornberry (108.3M for).
- Ernst & Young ratified as auditor for FY2024 with 118.0M for, 297k against.
- Say-on-pay advisory vote passed with 101.6M for, 8.6M against.
- Meeting had 83.0% of outstanding shares present (118.3M of 142.5M shares).

## SEC filing metadata
- accession: 0001714899-24-000125
- form_type: 8-K
- ticker: DNLI
- cik: 0001714899
- company_name: Denali Therapeutics Inc.
- filed_at: 2024-05-31T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1714899/000171489924000125/0001714899-24-000125-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1714899/000171489924000125/dnli-20240531.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001714899-24-000125
- JSON: https://secwatch.observer/filing/0001714899-24-000125.json
- Plain text: https://secwatch.observer/filing/0001714899-24-000125.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.